P0786 : 100% SVR12 with ledipasvir/sofosbuvir±ribavirin for 12 weeks in Japanese patients with chronic genotype 1 hepatitis C virus who previously failed therapy with protease inhibitor + pegylated interferonα + ribavirin
Year: 2015
Type: conference-abstract
Source: Journal of Hepatology
Authors: M. Omata, T. Takehara, O. Yokosuka, N. Sakamoto, M. Korenagai, H. Mochizuki, K. Nakane, H. Enomoto, M. Yanase, H. Toyoda, F. Ikeda, T. Genda, T. Umemura, H. Yatsuhashi, T. Ide, N. Toda, K. Nirei, Y. Ueno, Y. Nishigaki, S. De-Oertel, B. Gao, H. Dvory-Sobol, A. Ishizaki, M. Omote, P.S. Pang, S.J. Knox, W.T. Symonds, J.G. McHutchison, N. Izumi, M. Mizokami
Institutions: Yamanashi Prefectural Hospital Organization, Osaka University Hospital, The University of Osaka, Chiba University, Hokkaido University, National Center for Global Health and Medicine, Akita City Hospital, Hyogo Medical University, Ogaki Municipal Hospital, Okayama University, Juntendo University, Shinshu University, Nagasaki Medical Center, National Hospital Organization, Kurume University, Mitsui Memorial Hospital, Nihon University, Yamagata University, Gifu Municipal Hospital, Gilead Sciences (United States), Gilead Sciences (Japan), Musashino Red Cross Hospital
Language: English
Topic: Hepatitis C virus research
Subfield: Hepatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W970490344